T1	Participants 76 122	in HIV-associated B-cell non-Hodgkin lymphoma.
T2	Participants 198 262	immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL).
T3	Participants 713 732	HIV-associated NHL.
T4	Participants 962 983	48 evaluable patients
T5	Participants 1078 1099	53 evaluable patients
T6	Participants 1479 1503	HIV-associated lymphoma.
